You are here

squamous cell carcinoma of the head and neck

ALX lays off 30% of staff to pay for more trials of CD47 blocker

Fierce Biotech

Wed, 03/5/25 - 12:00 pm

clinical trials

squamous cell carcinoma of the head and neck

Merus's Petosemtamab Shows 40.4% Response Rate in Head & Neck Cancer Trial

Stock Titan

Mon, 12/2/24 - 10:57 am

squamous cell carcinoma of the head and neck

head and neck cancer

Nanobiotix gets FDA fast track status for NBTXR3 to investigate in head and neck cancer

Pharmaceutical Business Review

Tue, 02/11/20 - 10:29 am

squamous cell carcinoma of the head and neck

Merck claims a needed win for Keytruda with interim OS data in head and neck cancer

Endpoints

Wed, 07/25/18 - 11:03 am

clinical trials

squamous cell carcinoma of the head and neck

Bristol-Myers Squibb Reveals Regulatory Approvals For Opdivo Marketing Application

Yahoo/Benzinga

Mon, 07/18/16 - 11:07 am

Bristol-Myers Squibb

squamous cell carcinoma of the head and neck